Bulk and single-cell RNA sequencing of tumor-infiltrating lymphocytes revealed the existence of CD4+ T cells with cytolytic phenotype [8,9,10,11,12] and the presence of CD4+ T cells with direct killing activity against human tumor tissues [13], introducing CD4+ T cells as critical players in the regulation of anti-tumor immunity. The gene discussed is CD4; the disease is neoplasm.